UHT
Next earnings: Jul 27, 2026
Signal
Leaning Bearish1
Price
1
Move-0.34%Quiet session
Volume
1
Volume0.7× avgNormal activity
Technical
1
RSIRSI 43Momentum negative
PRICE
Prev Close
40.70
Open
40.73
Day Range40.10 – 40.76
40.10
40.76
52W Range35.26 – 44.70
35.26
44.70
56% of range
VOLUME & SIZE
Avg Volume
65.2K
FUNDAMENTALS
P/E Ratio
31.7x
EPS (TTM)
Div Yield
0.06%
Beta
0.50
Low vol
Performance
1D
-0.34%
5D
+0.12%
1M
-0.64%
3M
+1.15%
6M
+6.12%
YTD
+3.44%
1Y
+3.39%
Best: 6M (+6.12%)Worst: 1M (-0.64%)
Quick Read
TrendInsufficient MA data
Momentum
BULLISH
revenue +51% YoY · 90% gross margin
Valuation
EXPENSIVE
P/E 32x vs ~20x sector
Health
WEAK
CR 0.0 (low) · FCF $3.58/sh
Neutral
Key MetricsTTM
Market Cap$562.75M
Revenue TTM$148.66M
Net Income TTM$17.85M
Free Cash Flow$49.57M
Gross Margin90.5%
Net Margin12.0%
Operating Margin36.2%
Return on Equity11.4%
Return on Assets3.2%
Debt / Equity2.63
Current Ratio0.00
EPS TTM$1.29
Alpha SignalsFull Analysis →
What Moves This Stock

10-year Treasury yield movements - REIT valuations compress when risk-free rates rise, making 4-5% dividend yields less attractive

UHS financial health and credit profile - 90% tenant concentration means parent company's hospital utilization, behavioral health census, and leverage ratios directly impact lease coverage

Healthcare real estate transaction cap rates - private market valuations for medical office buildings (typically 6-8% cap rates) influence NAV estimates

Acquisition pipeline and deployment of capital - ability to source accretive deals at 7-9% yields on invested capital drives growth expectations

Macro Sensitivity
Economic Cycle

low - Healthcare services demonstrate recession-resistant demand characteristics, with hospital admissions and medical office visits driven by demographic needs rather than discretionary spending. UHS's behavioral health facilities (substance abuse, psychiatric care) maintain high utilization across economic cycles. However, Medicaid reimbursement pressures during state budget deficits and uninsured patient volumes can modestly impact tenant cash flows during severe downturns.

Interest Rates

High sensitivity to interest rate movements through multiple channels: (1) Valuation compression as 10-year Treasury yields rise reduces REIT multiple attractiveness versus bonds; (2) 2.44x debt-to-equity ratio means refinancing risk and higher debt service costs when rates increase; (3) Acquisition economics deteriorate as borrowing costs rise relative to property cap rates, reducing accretive deal flow. Each 100bp increase in 10-year yields typically compresses healthcare REIT multiples by 10-15%.

Key Risks

Shift toward outpatient and ambulatory care reduces demand for traditional hospital-adjacent medical office space, potentially obsoleting older Class B properties in the portfolio

Medicare reimbursement cuts or Medicaid expansion reversals could pressure UHS operating margins and lease coverage ratios, particularly for behavioral health facilities dependent on government payers

Regulatory changes to certificate-of-need laws or facility licensing requirements could impact property values and re-tenanting options if UHS vacates

Investor Profile

dividend - 4-5% dividend yield attracts income-focused investors seeking healthcare sector exposure with lower volatility than hospital operators. The stable cash flow profile and REIT tax structure appeal to retirees and income funds, though limited growth prospects (3-4% annual FFO growth) deter growth investors. Value investors may find appeal during rate-driven selloffs when yield spreads widen versus Treasuries.

Watch on Earnings
10-year Treasury yield (GS10) - primary driver of REIT valuation multiples and cost of capitalUHS quarterly earnings and same-facility revenue growth - leading indicator of tenant health and lease coverageHealthcare real estate transaction cap rates from industry reports (CBRE, JLL) - private market valuation benchmarkSOFR and term loan spreads - refinancing costs for debt maturities
Health Radar
1 strong1 watch4 concern
29/100
Liquidity
0.00Concern
Leverage
2.63Concern
Coverage
1.9xConcern
ROE
11.4%Watch
ROIC
146.1%Strong
Cash
$7MConcern
ANALYST COVERAGE1 analysts
HOLD
Hold
1100%
0 Buy (0%)1 Hold (100%)0 Sell (0%)
Full report →
Stock Health
Composite Score
2 of 5 signals bullish
6/10
Technicals
RSI RangeRSI 43 — Bearish momentum
Volume
Volume FlowAccumulation — institutional buying
Fundamentals
Last EarningsBeat estimates
Analyst ConsensusHold
~
LiquidityCurrent Ratio 0.00 — liquidity risk
Upcoming Events
EEarnings ReportMay 4, 2026
Tomorrow
DEx-Dividend DateJul 31, 2026
In 89 days
PDividend PaymentAug 10, 2026
In 99 days
Technicals
Technical SetupBEARISH
Technicals →

Trend

PullbackGolden Cross · 50D leads 200D by 2.9%

-1.0% vs SMA 50 · +1.9% vs SMA 200

Momentum

RSI43.0
Momentum fading
MACD-0.16
Below zero — bearish pulse · compressing
Market Position
Price Levels
52W High
$44.70+10.2%
EMA 50
$40.87+0.8%
Current
$40.56
EMA 200
$35.93-11.4%
52W Low
$35.26-13.1%
52-Week RangeMid-range
$35.2656th %ile$44.70
Squeeze SetupVolume-based
Moderate Squeeze Setup

Accumulation pattern present — more buying days than selling over the past 20 sessions. Volume conditions support gradual price improvement.

20-Day Money Flow
Acc days:6
Dist days:5
Edge:+1 acc
Volume Context
Avg Vol (50D)59K
Recent Vol (5D)
63K+8%

Based on volume distribution analysis. Direct short interest data (short float %, days to cover) is not available in current data sources.

Earnings & Analysts

ANALYST ESTIMATES

Consensus of 14 analysts
Analyst revisions:EPS↑ Revised UpRevenue↑ Revised Up

Analyst consensus estimates · Actuals replace estimates as reported

YearRevenue Est.Rev GthEPS Est.EPS GthRangeAnalysts
FY2023
$160.5M
$128.4M$192.6M
$9.78
±20%
High14
FY2025
$100.0M
$100.0M$100.0M
-37.7%$1.58-83.8%
Low1
FY2026(current)
$99.7M
$99.7M$99.7M
-0.3%$1.73+9.5%
Low1
Range confidence:Tight (high)ModerateWide (low)
Earnings HistoryUHT
Last 8Q
+16.5%avg beat
Beat 4 of 8 quartersMissed 3 Estimates rising
Q4'03
+2%
Q1'04
-15%
Q2'04
-2%
Q4'04
-2%
Q1'05
+11%
Q3'05
+26%
Q4'05
+113%
Q4'06
Beat
Miss
Estimate
Deeper color = bigger beat/miss
Insider Activity
SEC Filings →
6 Buys/0 SellsNet Buying
Miller Alan BDir
$453K
Oct 29
BUY
Mccadden Robert FDir
$75K
May 9
BUY
Miller Alan BDir
$208K
Apr 26
BUY
Miller Alan BDir
$103K
May 3
BUY
Mccadden Robert FDir
$48K
Mar 10
BUY
Miller Alan BDir
$98K
Mar 7
BUY
Financials
Dividends7.32% yield
+1.2% avg annual growth
Annual Yield7.32%
Quarterly Div.$0.7450
Est. Annual / Share$2.98
FrequencyQuarterly
Q2'24
Q3'24
Q4'24
Q1'25
Q2'25
Q3'25
Q4'25
Q1'26

Dividend per payment — last 8 periods

INSTITUTIONAL OWNERSHIP

1
ProShare Advisors LLC
147K
2
EXCHANGE TRADED CONCEPTS, LLC
51K
3
Nuveen, LLC
26K
4
ALTFEST L J & CO INC
22K
5
Skopos Labs, Inc.
20K
6
State of Alaska, Department of Revenue
15K
7
Independent Wealth Network Inc.
15K
8
Sumitomo Mitsui Trust Holdings, Inc.
13K
News & Activity

UHT News

20 articles · 4h ago

About

universal health realty income trust is a real estate company located in 154 n gulph rd, king of prussia, pennsylvania, united states.

Industry
Lessors of Nonresidential Buildings (except Miniwarehouses)
CEO
Alan Miller
Cheryl K. RamaganoSenior Vice President of Operations, Treasurer & Secretary
Karla PetersonVice President of Acquisitions & Development
Charles F. BoyleSenior Vice President & Chief Financial Officer
PeersReal Estate(7 companies)
Screen sector →
SymbolPriceDay %Mkt CapP/ERev GrwMarginELO
UHT
$40.56-0.34%$563M31.4+18.1%1775.3%1500
$216.91-0.20%$153.1B107.8+3582.4%878.3%1511
$141.41-0.43%$131.8B35.4+717.6%3880.1%1505
$1085.03+0.20%$107.0B75.1+585.3%1457.9%1524
$181.61-0.60%$84.6B29.4+511.4%2376.5%1491
$200.70-0.12%$69.0B50.3+1004.0%2140.8%1518
$202.44-0.62%$65.8B14.3+671.9%7251.1%1507
Sector avg-0.30%49.1+1013.0%2822.8%1508